Mitigation of MAFLD in High Fat-High Sucrose-Fructose Fed Mice by a Combination of Genistein Consumption and Exercise Training

References

• Booth FW, Roberts CK, Thyfault JP, Ruegsegger GN, Toedebusch RG. Role of inactivity in chronic diseases: evolutionary insight and pathophysiological mechanisms. Phys Rev. 2017;97:1351–1402.
   PubMed Web of Science ®Google Scholar
• Eslam M, Newsome PN, Sarin SK, et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consencus statement. J Hepatol. 2020;73(1):202–209. doi:10.1016/j.jhep.2020.03.039
   PubMed Web of Science ®Google Scholar
• Tilg H, Moschen AR, Roden M. NAFLD and diabetes mellitus. Nat Rev Gastroenterol Hepatol. 2017;14(1):32–42. doi:10.1038/nrgastro.2016.147
   PubMed Web of Science ®Google Scholar
• Fabbrini E, Magkos F, Mohammed SS, et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A. 2009;106(36):15430–15435. doi:10.1073/pnas.0904944106
   PubMed Web of Science ®Google Scholar
• Kim D, Choi S-Y, Park EH, et al. Nonalcoholic fatty liver disease is associated with coronary artey calcification. Hepatology. 2012;56(2):605–613. doi:10.1002/hep.25593
   PubMed Web of Science ®Google Scholar
• Targher G, Mantovani A, Grander C, et al. Association between non-alcoholic fatty liver disease and impaired cardiac sympathetic/parasympathetic balance in subjects with and without type 2 diabetes- The Cooperative Health Research in South Tyrol (CHRIS)-NALFD sub-study. Nutr Metab Cardiovasc Dis. 2021;31(12):3464–3473. doi:10.1016/j.numecd.2021.08.037
   Web of Science ®Google Scholar
• Gong H, Liu X, Cheng F. Relationship between non-alcoholic fatty liver disease and cardiac arrhythmia: a systematic review and meta-analysis. J Int Med Res. 2021;49(9):3000605211047074. doi:10.1177/03000605211047074
   Web of Science ®Google Scholar
• Park JH, Kim G, Kim H, et al. The association of hepatic steatosis and fibrosis with heart failure and mortality. Cardiovasc Diabetol. 2021;20(1):197. doi:10.1186/s12933-021-01374-8
   Web of Science ®Google Scholar
• Simon TG, Roelstraete B, Hagstrom H, Sundstrom J, Ludvigsson JF. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort. Gut. 2021:325724. doi:10.1136/gutjnl-2021-325724
   Web of Science ®Google Scholar
• Musso G, Gambino R, Cassader M, Pagano GA. Meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver. Hepatology. 2010;52(1):79–104. doi:10.1002/hep.23623
   PubMed Web of Science ®Google Scholar
• Bril F, Barb D, Portillo-Sanchez P, et al. Metabolic and histological implications of intrahepatic triglyceride content in nonalcoholic fatty liver disease. Hepatology. 2017;65(4):1132–1144. doi:10.1002/hep.28985
   PubMed Web of Science ®Google Scholar
• Diehl AM, Day C, Longo DL. Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis. N Engl J Med. 2017;377(21):2063–2072. doi:10.1056/NEJMra1503519
   PubMed Web of Science ®Google Scholar
• Manne V, Handa P, Kowdley KV. Pathophysiology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. Clin Liver Dis. 2018;22(1):23–37. doi:10.1016/j.cld.2017.08.007
   PubMed Web of Science ®Google Scholar
• Association AG. American gastroentrological association medical position statement: nonalcoholic fatty liver disease. Gastroenterol. 2002;123(5):1702–1704. doi:10.1053/gast.2002.36569
   Google Scholar
• Kugelmas M, Hill DB, Vivian B, Marsano L, McClain CJ. Cytokines and NASH: a pilot study o fthe effects of lifestyle modification and vitamin E. Hepatology. 2003;38(2):413–419. doi:10.1053/jhep.2003.50316
   PubMed Web of Science ®Google Scholar
• van der Windt DJ, Sud V, Zhang H, Tsung A, Huang H. The effects of physical exercise on fatty liver disease. Gene Exp. 2018;18(2):89–101. doi:10.3727/105221617X15124844266408
   PubMedGoogle Scholar
• Cho J, Kim S, Lee S, Kang H. Effect of training intensity on nonalcoholic fatty liver disease. Med Sci Sports Exerc. 2015;47(8):1624–1634. doi:10.1249/MSS.0000000000000595
   Web of Science ®Google Scholar
• Keating SE, George J, Johnson NA. The benefits of exercise for patients with non-alcoholic fatty liver disease. Expert Rev Gastroenterol Hepatol. 2015;9(10):1247–1250. doi:10.1586/17474124.2015.1075392
   PubMed Web of Science ®Google Scholar
• Thoma C, Day CP, Trenell MI. Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systemic review. J Hepatol. 2012;56(1):255–266. doi:10.1016/j.jhep.2011.06.010
   PubMed Web of Science ®Google Scholar
• Hallsworth K, Thoma C, Hollingsworth KG, et al. Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial. Clin Sci. 2015;129(12):1097–1105. doi:10.1042/CS20150308
   PubMed Web of Science ®Google Scholar
• Kantartzis K, Thamer C, Peter A, et al. High cardiorespiratory fitness is an independent predictor of the reduction in liver fat during a lifestyle intervention in non-alcoholic fatty liver disease. Gut. 2009;58(9):1281–1288. doi:10.1136/gut.2008.151977
   PubMed Web of Science ®Google Scholar
• Bacchi E, Negri C, Targher G, et al. Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetes subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial). Hepatology. 2013;58(4):1287–1295. doi:10.1002/hep.26393
   PubMed Web of Science ®Google Scholar
• Keating SE, Hackett DA, Parker HM, et al. Effect of aerobic training dose on liver fat and visceral adiposity. J Hepatol. 2015;63(1):174–182. doi:10.1016/j.jhep.2015.02.022
   PubMed Web of Science ®Google Scholar
• Trefts E, Williams AS, Wasserman DH. Exercise and the regulation of hepatic metabolism. Prog Mol Biol Transl Sci. 2015;135:203–225.
   PubMed Web of Science ®Google Scholar
• Kiens B. Skeletal muscle lipid metabolism in exercise and insulin resistance. Physiol Rev. 2006;86(1):205–243. doi:10.1152/physrev.00023.2004
   PubMed Web of Science ®Google Scholar
• Golabi P, Locklear CT, Austin P, et al. Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: systematic review. World J Gastroenterol. 2016;22(27):6318–6327. doi:10.3748/wjg.v22.i27.6318
   PubMed Web of Science ®Google Scholar
• Zaheer K, Humayoun Akhtar M. An updated review of dietary isoflavones: nutrition, processing, bioavailability and impacts on human health. Crit Rev Food Sci Nutr. 2017;57(6):1280–1293. doi:10.1080/10408398.2014.989958
   PubMed Web of Science ®Google Scholar
• Sharifi-Rad J, Quispe C, Imran M, et al. Genistein: an integrative overview of its mode of action, pharmacological properties, and health benefits. Oxid Med Cell Longev. 2021;2021:3268136. doi:10.1155/2021/3268136
   PubMed Web of Science ®Google Scholar
• Nazari-Khanamiri F, Ghasemnejad-Berenji M. Cellular and molecular mechanisms of genistein in prevention and treatment of diseases: an overview. J Food Biochem. 2021;45(11). doi:10.1111/jfbc.13972
   Web of Science ®Google Scholar
• Ziegler RG. Phytoestrogens and breast cancer. Am J Clin Nutr. 2004;79(2):183–184. doi:10.1093/ajcn/79.2.183
   Web of Science ®Google Scholar
• Park Y-J, Ko JW, Jeon S, Kwon YH. Protective effects of genistein against neuronal degeneration in ApoE −/− mice fed a high-fat diet. Nutrients. 2016;8(11):1–11. doi:10.3390/nu8110692
   Web of Science ®Google Scholar
• Rajput MS, Sarkar PD. Modulation of neuro-inflammatory condition, acetlcholinesterase and antioxidant levels by genistein attenuates diabetes associated cognitive decline in mice. Chem Biol Interact. 2017;268:93–102. doi:10.1016/j.cbi.2017.02.021
   PubMed Web of Science ®Google Scholar
• Lee YM, Choi JS, Kim MH, Jung MH, Lee YS, Song J. Effects of dietary genistein on hepatic lipid metabolism and mitochondrial function in mice fed high-fat diets. Nutrition. 2006;22(9):956–964. doi:10.1016/j.nut.2005.12.014
   PubMed Web of Science ®Google Scholar
• Choi JS, Song J. Effect of genistein on insulin resistance, renal lipid metabolism, and antioxidative activities in ovariectomized rats. Nutrition. 2009;25(6):676–685. doi:10.1016/j.nut.2008.11.027
   PubMed Web of Science ®Google Scholar
• Kim MH, Kang KS, Lee YS. The inhibitory effect of genistein on hepatic steatosis is linked to visceral adipocyte metabolism in mice with diet-induced non-alcoholic fatty liver disease. Br J Nutr. 2010;104(9):1333–1342. doi:10.1017/S0007114510002266
   PubMed Web of Science ®Google Scholar
• Zamani-Garmsiri F, Hashemnia SMR, Shabani M, Bagherieh M, Emamgholipour S, Meshkani R. Combination of metformin and genistein alleviates non-alcoholic fatty liver disease in high-fat diet-fed mice. J Nutr Biochem. 2021;87:108505. doi:10.1016/j.jnutbio.2020.108505
   PubMed Web of Science ®Google Scholar
• Rockwood SS, Broderick TL, Al-Nakkash L. Feeding obese diabetic mice a genistein diet induces thermogenic and metabolic change. J Med Food. 2018;21(4):332–339. doi:10.1089/jmf.2017.0084
   Web of Science ®Google Scholar
• Rockwood SS, Mason D, Lord R, Lamar P, Prozialeck WC, Al-Nakkash L. Genistein diet improves body weight, serum glucose and triglyceride levels in both male and female ob/ob mice. Diabetes Metab Syndr Obess. 2019;12:20111–22021.
   Web of Science ®Google Scholar
• Witayavanitkul N, Werwatganon D, Chayanupatkul M, Klaikeaw N, Sanguanrungsirikul S, Siriviriyakul P. Genistein and exercise modulated lipid peroxidation and improved statohepatitis in ovariectomized rats. BMC Complement Altern Med. 2020;20(1):162. doi:10.1186/s12906-020-02962-z
   Web of Science ®Google Scholar
• Sabag A, Keating SE, Way KL, et al. The association between cardiorespiratory fitness, liver fat and insulin resistance in adults with or without type 2 diabetes: a cross sectional-analysis. BMC Sports Sci Med Rehabil. 2021;13(1):40. doi:10.1186/s13102-021-00261-9
   Web of Science ®Google Scholar
• Abdelmalek MF, Suzuki A, Guy C, et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology. 2010;51:1961–1971.
   PubMed Web of Science ®Google Scholar
• Bray GA, Nielsen SJ, Popkin BM. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr. 2004;79(4):537–543. doi:10.1093/ajcn/79.4.537
   PubMed Web of Science ®Google Scholar
• Harrington S. The role of sugar-sweetened beverage consumption in adolescent obesity: a review of the literature. J Sch Nurs. 2008;24(1):3–12. doi:10.1177/10598405080240010201
   Web of Science ®Google Scholar
• Forshee RA, Storey ML. Total beverage consumption and beverage choices among children and adolescents. Int J Food Sci Nutr. 2003;54(4):297–307. doi:10.1080/09637480120092143
   PubMed Web of Science ®Google Scholar
• Schwimmer JB, Deutsch R, Kahen T, Lavine JE, Stanley C, Behling C. Prevalence of fatty liver in children and adolescents. Pediatrics. 2006;118(4):1388–1393. doi:10.1542/peds.2006-1212
   PubMed Web of Science ®Google Scholar
• Schwimmer JB, Behling C, Newbury R, et al. Histopathology of pediatric nonalcoholic fatty liver disease. Hepatology. 2005;42(3):641–649. doi:10.1002/hep.20842
   Web of Science ®Google Scholar
• Ortega-Santos CP, Al-Nakkash L, Whisner CM. Exercise and/or genistein treatment impact gut microbiota and inflammation after 12 weeks on a high-fat, high-sugar diet in C57BL/6 mice. Nutrients. 2020;12(11):3410. doi:10.3390/nu12113410
   Web of Science ®Google Scholar
• Shapiro A, Mu W, Roncal C, Cheng K-Y, Johnson RJ, Scarpace PJ. Fructose-induced leptin resistance exacerbates weight gain in response to subsequent high-fat feeding. Am J Physiol Regul Integr Comp Physiol. 2008;295(5):R1370–1375. doi:10.1152/ajpregu.00195.2008
   PubMed Web of Science ®Google Scholar
• Al-Nakkash L, Clarke LL, Rottinghaus GE, Chen YJ, Cooper K, Rubin LJ. Dietary genistein stimulates anion secretion across female murine intestine. J Nutr. 2006;136(11):2785–2790. doi:10.1093/jn/136.11.2785
   Web of Science ®Google Scholar
• Xu X, Wang HJ, Murphy PA, Cook L, Hendich S. Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr. 1994;124(6):825–832. doi:10.1093/jn/124.6.825
   PubMed Web of Science ®Google Scholar
• James DE, Burleigh KM, Kragen EW, Chisholm DJ. Effect of acute exercise and prolonged training on insulin response to intravenous glucose in vivo in rat. J Appl Physiol. 1983;55(6):1660–1664. doi:10.1152/jappl.1983.55.6.1660
   Web of Science ®Google Scholar
• Broderick TL, Sennott JM, Gutkowska J, Jankowski M. Anti-inflammatory and angiogenic effects of exercise training in cardiac muscle of diabetic mice. Diabetes Metab Syndr Obes. 2019;12:565–573. doi:10.2147/DMSO.S197127
   PubMed Web of Science ®Google Scholar
• Hoydal MA, Wislofff U, Kemi OJ, Ellingsen O. Running speed and maximal oxygen uptake in rats and mice: practical implications for exercise training. Eur J Cardiovasc Prev Rehabil. 2007;14(6):753–760. doi:10.1097/HJR.0b013e3281eacef1
   PubMedGoogle Scholar
• Colberg SR, Sigal RJ, Fernhall B, et al. Exercise and type 2 diabetes: the American college of sports medicine and the American diabetes association: joint position statement. Diabetes Care. 2010;33(12):e147–167. doi:10.2337/dc10-9990
   PubMed Web of Science ®Google Scholar
• Kato K-I, Takeshita Y, Misu H, Zen Y, Kaneko S, Takamura T. Liver steatosis is associated with insulin resistance in skeletal muscle rather than in the liver in Japanese patients with non-alcoholic fatty liver disease. J Diabetes Investig. 2015;6:158–163. doi:10.1111/jdi.12271
   Web of Science ®Google Scholar
• Eckard C, Cole R, Lockwood J, et al. Prospective histopathologic evaluation of lifestyle modification in nonalcoholic fatty liver disease: a a randomized trial. Therap Adv Gastroenterol. 2013;6(4):249–259. doi:10.1177/1756283X13484078
   PubMed Web of Science ®Google Scholar
• Jin YJ, Kim KM, Hwang SS, et al. Exercise and diet modification in non-obese non-alcoholic fatty liver disease: analysis of biopsies of living liver donors. J Gastroenterol Hepatol. 2012;27(8):1341–1347. doi:10.1111/j.1440-1746.2012.07165.x
   Web of Science ®Google Scholar
• Rehman K, Ali MB, Akash MSH. Genistein enhances the secretion of glucagon-like peptide-1 (GLP-1) via downregulation of inflammatory responses. Biomed Pharmacother. 2019;112:108670. doi:10.1016/j.biopha.2019.108670
   PubMed Web of Science ®Google Scholar
• Zheng W, Li L, Li H. Phytochemicals modulate pancreatic islet B cell function through glucagon-like peptide-1-related mechanisms. Biochem Pharmacol. 2021;197:114817. doi:10.1016/j.bcp.2021.114817
   Web of Science ®Google Scholar
• Kwon YM, Oh SW, Hwang SS, Lee CB, Kwon H, Chung GE. Association of nonalcoholic fatty liver disease with components of metabolic syndrome according to body mass index in Korean adults. Am J Gastroenterol. 2012;107(12):1852–1858. doi:10.1038/ajg.2012.314
   PubMed Web of Science ®Google Scholar
• Sayiner M, Koenig A, Henry L, Younossi ZM. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in the United States and the rest of the world. Clin Liver Dis. 2016;20(2):205–214. doi:10.1016/j.cld.2015.10.001
   PubMed Web of Science ®Google Scholar
• Hebbard L, George J. Animal models of nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol. 2011;8(1):35–44. doi:10.1038/nrgastro.2010.191
   PubMed Web of Science ®Google Scholar
• Ouyang X, Cirillo P, Sautin Y, et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol. 2008;48(6):993–999. doi:10.1016/j.jhep.2008.02.011
   PubMed Web of Science ®Google Scholar
• Bertot LC, Adams LA. The natural course of non-alcoholic fatty liver disease. Int J Mol Sci. 2016;17:774.
   PubMed Web of Science ®Google Scholar
• Jahn D, Kircher S, Hermanns HM, Geier A. Animal models of NAFLD from a hepatologist’s point of view. Biochim Biophys Acta Mol Basis Dis. 2019;1865(5):943–953. doi:10.1016/j.bbadis.2018.06.023
   PubMed Web of Science ®Google Scholar
• Zhong F, Zhou X, Xu J, Gao L. Rodent models of nonalcoholic fatty liver disease. Digestion. 2020;101(5):522–535. doi:10.1159/000501851
   PubMed Web of Science ®Google Scholar
• Berardo C, Di Pasqua LG, Cagna M, Richelmi P, Vairetti M, Ferrigno A. Nonalcolhic fatty liver disease and non-alcoholic steatohepatitis: current issues and future perspectives in preclinical and clinical research. Int J Mol Sci. 2020;21(24):9646. doi:10.3390/ijms21249646
   Web of Science ®Google Scholar
• Zhang H, Leveille M, Courty E, Gunes A, Nguyen BN, Estall JL. Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease. Am J Physiol Endocrinol Metab. 2020;319(5):E863–E876. doi:10.1152/ajpendo.00321.2020
   PubMed Web of Science ®Google Scholar
• Ainsworth BE, Haskell WL, Herrmann SD, et al. compendium of physical activities: a second update of codes and MET values. Med Sci Sports Exerc. 2011;43(8):1575–1581. doi:10.1249/MSS.0b013e31821ece12
   PubMed Web of Science ®Google Scholar
• Broderick TL, Jankowski M, Gutkowska J. The effects of exercise training and caloric restriction on the cardiac oxytocin natriuretic peptide system in the diabetic mouse. Diabetes Metab Syndr Obes. 2017;10:27–36. doi:10.2147/DMSO.S115453
   Web of Science ®Google Scholar
• Morton GJ, Kaiyala KJ, Fisher JD, Ogimoto K, Schwartz MW, Wisse BE. Identification of a physiological role for leptin in the regulation of ambulatory activity and wheel running in mice. Am J Physiol Endocrinol Metab. 2011;300(2):E392–401. doi:10.1152/ajpendo.00546.2010
   Web of Science ®Google Scholar
• Song G-Y, Ren L-P, Chen S-C, et al. Similar changes in muscle lipid metabolism are induced by chronic high-fructose feeding and high-fat feeding in C57BL/J6 mice. Clin Exp Pharmacol Physiol. 2012;39(12):1011–1018. doi:10.1111/1440-1681.12017
   Web of Science ®Google Scholar
• Turner N, Bruce CR, Beale SM, et al. Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes. 2007;56(8):2085–2092. doi:10.2337/db07-0093
   PubMed Web of Science ®Google Scholar
• Yang JY, Lee SJ, Park HW, Cha YS. Effect of genistein with carnitine administration on lipid parameters and obesity in C57Bl/6J mice fed a high-fat diet. J Med Food. 2006;9(4):459–467. doi:10.1089/jmf.2006.9.459
   PubMed Web of Science ®Google Scholar
• Yalniz M, Bahcecioglu IH, Kuzu N, et al. Preventative role of genistein in an experimental non-alcoholic steatohepatitis model. J Gastroenterol Hepatol. 2007;22(11):2009–2014. doi:10.1111/j.1440-1746.2006.04681.x
   PubMed Web of Science ®Google Scholar
• Arunkumar E, Karthik D, Anuradha CV. Genistein sensitizes hepatic insulin signaling and modulates lipid regulatory genes through p70 ribosomal S6 kinase-1 inhibition in high-fat-high fructose diet-fed mice. Pharm Biol. 2013;51(7):815–824. doi:10.3109/13880209.2013.766896
   PubMed Web of Science ®Google Scholar
• Consoli A, Nurjhan N, Capani F, Gerich J. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes. 1989;38(5):550–557. doi:10.2337/diab.38.5.550
   PubMed Web of Science ®Google Scholar
• Firth RG, Bell PM, Marsh HM, Hansen I, Rizza RA. Postprandial hyperglycemia in patients with noninsulin-dependent diabetes mellitus. Role of hepatic and extrahepatice tissues. J Clin Invest. 1986;77(5):1525–1532. doi:10.1172/JCI112467
   Web of Science ®Google Scholar
• Pereira CD, Azevedo I, Monteiro R, Martins MJ. 11B-hydroxysteroid dehydrogenase type-1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus. Diabetes Obes Metab. 2012;14(10):869–881. doi:10.1111/j.1463-1326.2012.01582.x
   PubMed Web of Science ®Google Scholar
• Krarup T, Krarup T, Hagen C. Do patients with type 2 diabetes mellitus have an increased prevalence of Cushing’s syndrome. DIabets Metab Res Rev. 2012;28(3):219–227. doi:10.1002/dmrr.2262
   Web of Science ®Google Scholar
• Zhang X, Yang S, Chen J, Su Z. Unravelling the regulation of hepatic gluconeogenesis. Front Endocrinol. 2019;9:802. doi:10.3389/fendo.2018.00802
   PubMed Web of Science ®Google Scholar
• Tagawa N, Kubota S, Kobayashi Y, Kato I. Genistein inhibits glucocorticoid amplification in adipose tissue by suppression of 11Beta-hydroxysteroid dehydrogenase type 1. Steroids. 2015;93:77–86. doi:10.1016/j.steroids.2014.11.003
   Web of Science ®Google Scholar
• van Poelje PD, Potter SC, Chandramouli VC, Landau BR, Dang Q, Erion MD. Inhibition of fructose 1,6-bisphosphatase reduces excessive endogenous glucose production and attenuates hyperglycemia in zucker diabetic fatty rats. Diabetes. 2006;55(6):1747–1754. doi:10.2337/db05-1443
   Web of Science ®Google Scholar
• Horton JD, Goldstein JL, Brown MS. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest. 2002;109(9):1125–1131. doi:10.1172/JCI0215593
   PubMed Web of Science ®Google Scholar
• Li Y, Xu S, Mihaylova MM, et al. AMPK phosphorylates and inhibits SREBP activity to attenuate hepatic steatosis and atherosclerosis in diet-induced insulin resistant mice. Cell Metab. 2011;13(4):376–388. doi:10.1016/j.cmet.2011.03.009
   PubMed Web of Science ®Google Scholar
• Zhang C, Chen X, Zhu RM, et al. Endoplasmic reticulum stress is involved in hepatic SREBP-1c activation and lipid accumulation in fructose-fed mice. Toxicol Lett. 2012;212(3):229–240. doi:10.1016/j.toxlet.2012.06.002
   PubMed Web of Science ®Google Scholar
• Choi YR, Shim JH, Kim MJ. Genistin: a novel potent anti-adipogenic and anti-lipogenic agent. Molecules. 2020;25(9):2042. doi:10.3390/molecules25092042
   PubMed Web of Science ®Google Scholar
• Seidman L, Kruger A, Kegel-Hubner V, Seehofer D, Damm G. Influence of genistein on hepatic lipid metabolism in an in vitro model of hepatic steatosis. Molecules. 2021;26(4):1156. doi:10.3390/molecules26041156
   Web of Science ®Google Scholar
• Shukla A, Brandsch C, Bettzieche A, Hirche F, Stangl GL, Eder K. Isoflavone-poor soy protein alters lipid metabolism of rats by SREBP-mediated down-regulation of hepatic genes. J Nutr Biochem. 2007;18(5):313–321. doi:10.1016/j.jnutbio.2006.05.007
   Web of Science ®Google Scholar
• Wu H, Jin M, Han D, et al. Protective effects of aerobic swimming training on high-fat diet induced nonalcoholic fatty liver disease: regulation of lipid metabolism via PANDER-AKT pathway. Biochem Biophys Res Commun. 2015;458(4):862–869. doi:10.1016/j.bbrc.2015.02.046
   Web of Science ®Google Scholar
• Suk M, Shin Y. Effect of high-intensity exercise and high-fat diet on lipid metabolism in the liver of rats. J Exerc Nutr Biochem. 2015;19(4):289–295. doi:10.5717/jenb.2015.15122303
   Google Scholar
• Tsuzuki T, Shinozaki S, Nakamoto H, et al. Voluntary exercise can ameliorate insulin resistance by reducing iNOS-mediated S-nitrosylation of Akt in the liver in obese rats. PLoS One. 2015;10(7):e0132029. doi:10.1371/journal.pone.0132029
   PubMed Web of Science ®Google Scholar
• Rector RS, Thyfault JP, Morris RT, et al. Daily exercise increases hepatic fatty acid oxidation and prevents steatosis in Otsuka long-Evans Tokushima fatty rats. Am J Physiol Gastrointest Liver Physiol. 2008;294(3):G619–626. doi:10.1152/ajpgi.00428.2007
   PubMed Web of Science ®Google Scholar
• Cho J, Lee I, Kim D-H, et al. Effect of aerobic exercise training on non-alcoholic fatty liver disease induced by a high fat diet in C57BL/6 mice. J Exerc Nutr Biochem. 2014;18(4):339–346. doi:10.5717/jenb.2014.18.4.339
   PubMedGoogle Scholar